On June 3, 2014 Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) announced its sponsorship of the Lupus Foundation of America’s (LFA) eight national officeWalk to End Lupus Now™ events and its support of a variety of Lupus Awareness Month activities.Questcor Pharmaceuticals Inc (NASDAQ:QCOR) net profit margin is 36.80% and weekly performance is -1.77%. On last trading day company shares ended up $87.26. Analysts mean target price for the company is $86.14. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) distance from 50-day simple moving average (SMA50) is 7.09%.
On June 4, 2014 Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) the leader in antisense therapeutics, announced that management will present a company overview at the Goldman Sachs 35th Annual Global Healthcare Conference on Wednesday, June 11, 2014 at 8:40 a.m. PT in Rancho Palos Verdes, CA. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares advanced 10.24 % in last trading session and ended the day on $30.25. Gross Margin is -50.80% and its return on assets is -11.00%. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) quarterly performance is -42.12%.
On June 2, VIVUS, Inc (NASDAQ:VVUS)’s shares declined considerably after performing well in the last couple of days. Aspen Investment Fund LLC may make an offer to take over the drug maker, which is VVUS has stated in their regulatory filing with the SEC. However, looking at the filing done by the VVUS, there are certain points which need to be examined closely. VIVUS, Inc. (NASDAQ:VVUS) shares moved up 3.67% in last trading session and was closed at $5.09, while trading in range of $4.87 – $5.12. VIVUS, Inc. (NASDAQ:VVUS) year to date (YTD) performance is -43.94%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), reported longer-term follow up from its Phase 1 and pivotal Phase 2 trials of Iclusig® , its approved BCR-ABL inhibitor, in heavily pretreated patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) ended the last trading day at $6.69. Company weekly volatility is calculated as 4.36% and price to cash ratio as 6.83. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a positive weekly performance of 4.86%.
Minerco Resources Inc. (OTCMKTS:MINE) managed an impressive 8.88% run up yesterday, in spite of the bad news contained in the company’s latest 8-K. Minerco Resources Inc (OTCMKTS:MINE) On last trading day company shares ended up $0.0174 .
Leave a Reply